Abstract
judge feasibility and power, 25 TRD patients were referred from specialty psychiatric 23 practices. All were severely and chronically depressed and mostly had comorbid 
Positron emission tomography

183
Patients were scanned after washout (pre-treatment or baseline) and after 184 completion of the eight weeks of treatment at maximal tolerated dose (post-treatment).
185
Participants fasted for at least six hours before imaging; blood glucose was checked portions of BA32 and BA33 and will be referred to as subgenual/VMPFC (Fig 1B) .
231
Mean counts from each of these subgenual regions were compared pre-and post- left hemisphere). Additionally, the correlation matrix for glucose uptake across 248 amygdala, VMPFC, and hippocampus was calculated (S2 Table) .
249
Results
250
Clinical response
13
Drug wash out led frequently to increased insomnia, anxiety, and depression which were 252 the leading reasons for discontinuation by participants (N = 16). Side effects from O/F observed 253 reflected those commonly seen with this drug combination [28] . There were no suicide attempts 254 during the study. Nine participants completed the entire protocol (clinical MRI; drug washout; 255 O/F treatment; Pre-and Post-treatment PET scans). Clinical data are shown in Table 1 which 256 includes demographics, gender, family history of depression, illness onset, comorbidities (both 257 current and lifetime), failed treatments, and response designation. The HAMA and MADRS 258 scores as well as weights before and after treatment are displayed in S1 Table. The Responders showed increases in the left superior temporal and post-central gyri and 299 right precuneus. Significantly reduced metabolism was confined to a peak in the right 300 amygdaloid complex (see Fig 2) . Of note, liberalizing the threshold to 0 < 0.05 301 (uncorrected) revealed bilateral amygdala deactivations. Non-responders showed no 302 significant increases in metabolism following treatment. Areas of reduced metabolism 303 after treatment were found in non-responders in the bilateral cerebellum, lingual gyrus, 304 middle temporal gyrus, thalamus, midbrain, and dorsal cingulate gyrus (see Table 2 ).
305
For all patients as a group, no significant changes occurred in limbic structures in the 306 whole-brain image analysis. Table) . O/F tended to increase each region's inter-hemispheric functional connectivity 333 compared to baseline.
334
Amygdala region
335
Responders showed a significant reduction in mean glucose metabolism in the right 336 amygdala ROI (t(3) = 3.38, p = 0.04), while non-responders showed no change with 337 treatment (t(4) = -0.68, p = 0.54) (Fig 3A) . There was no change in left amygdala across all subjects (Fig 3B, r = -0 .20, p = 0.61). This correlation was significant in the 342 right amygdala (Fig 3B, r = -0 .70, p = 0.03). Because the hippocampus is near the 343 amygdala and the resolution of PET in this study is low, the post hoc hippocampal 344 region was also examined for changes in activity. perseverance.
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